Attenuated Cardiac Contractile Responsiveness to Insulin-Like Growth Factor I in Ventricular Myocytes from Biobreeding Spontaneous Diabetic Rats

J Ren
DOI: https://doi.org/10.1016/s0008-6363(00)00011-0
IF: 13.081
2000-01-01
Cardiovascular Research
Abstract:Objective: Insulin-like growth factor I (IGF-1) stimulates cardiac growth and contraction. but resistance to its action has been reported in diabetes. This study was to determine if IGF-1-induced cardiac contractile action is altered in rats genetically predisposed to diabetes. Method: Ventricular myocytes were isolated from spontaneously biobreeding diabetes-prone (BB/DP) rats and their diabetes-resistant littermates (BB/DR). Mechanical properties were evaluated in cardiomyocytes using a video-based edge-detection system. Myocytes were electrically stimulated at 0.5 Hz. Contractile properties analyzed included peak shortening (PS), time-to-PS (TPS) and time-to-90% relengthening (TR90). Intracellular Ca2+ transients were measured as changes in fura-2, fluorescence intensity (Delta FFI). Results: Myocytes from BB/DP rats displayed increased PS, prolonged TPS and TR90 as well as reduced resting FFI compared to the BB/DR group. IGF-1 (10(-10)-10(-6) M) caused a dose-dependent increase in PS in myocytes from BB/DR but not BB/DP rats. The increase of PS was blunted by IGF-1 antagonist H-1356, phosphatidylinositol-3 (PI-3) kinase inhibitor wortmannin. but not tyrosine kinase inhibitor genistein. None of these agents affected responses to IGF-1 in BB/DP myocytes. interestingly, IGF-1 elicited 3 comparable dose-dependent increase in Ca2+ transients in myocytes from both BB/DR and BB/DP rats. Conclusion: These results suggest that the attenuation of IGF-1-induced cardiac contractile response in chemically-induced diabetes also exists in diabetes or genetic origin, possibly due to mechanisms involving PI-3 kinase and intracellular Ca2+ sensitivity. (C) 2000 Elsevier Science B.V. All rights reserved.
What problem does this paper attempt to address?